Department of Otorhinolaryngology, Institute of Clinical Medicine, University of Oulu and Oulu University Hospital, Oulu, Finland.
CMAJ. 2013 May 14;185(8):E331-6. doi: 10.1503/cmaj.121852. Epub 2013 Apr 2.
Limited evidence exists as to the benefit of tonsillectomy in adult patients. We sought to determine the short-term efficacy of tonsillectomy for recurrent pharyngitis in adults.
We conducted a randomized, controlled, parallel-group trial at a tertiary care ear, throat and nose centre in Oulu, Finland, between October 2007 and December 2010. Adult patients with recurrent pharyngitis were randomly assigned to the control group (watchful waiting) or the tonsillectomy group. Our primary outcome was the difference in the proportion of patients with severe pharyngitis (severe symptoms and C-reactive protein level > 40 mg/L) within 5 months. Our secondary outcomes included differences between groups in proportions of patients who had episodes of pharyngitis with or without medical consultation, rates of pharyngitis and numbers of days with symptoms.
Of 260 patients referred for tonsillectomy because of recurrent pharyngitis, we recruited 86 participants for our study. Of these, 40 patients were randomly allocated to the control group, and 46 were randomly allocated to the tonsillectomy group. One patient in the control group and no patients in the tonsillectomy group had a severe episode of pharyngitis (difference 3%, 95% confidence interval [CI] -2% to 7%). Seventeen patients in the control group (43%) and 2 patients in the tonsillectomy group (4%) consulted a physician for pharyngitis (difference 38%, 95% CI 22% to 55%). Overall, 32 patients in the control group (80%) and 18 patients in the tonsillectomy group (39%) had an episode of pharyngitis during the 5-month follow-up (difference 41%, 95% CI 22% to 60%). The rate of pharyngitis and number of symptomatic days were significantly lower in the tonsillectomy group than in the control group.
There was no significant difference in the number of episodes of severe pharyngitis between the control and treatment groups, and episodes were rare. However, tonsillectomy resulted in fewer symptoms of pharyngitis, consequently decreasing the number of medical visits and days absent from school or work. For this reason, surgery may benefit some patients.
ClinicalTrials.gov, no. NCT00547391.
关于扁桃体切除术对成年患者的益处,现有证据有限。我们旨在确定扁桃体切除术治疗成人复发性咽炎的短期疗效。
我们在芬兰奥卢的一家三级保健耳鼻喉科中心进行了一项随机、对照、平行组试验,时间为 2007 年 10 月至 2010 年 12 月。患有复发性咽炎的成年患者被随机分配到对照组(观察等待)或扁桃体切除术组。我们的主要结局是在 5 个月内严重咽炎(严重症状和 C 反应蛋白水平>40mg/L)患者比例的差异。我们的次要结局包括两组间有无医疗咨询的咽炎发作比例、咽炎发生率和症状持续天数的差异。
在因复发性咽炎而转至扁桃体切除术的 260 例患者中,我们纳入了 86 例患者进行研究。其中,40 例患者被随机分配至对照组,46 例患者被随机分配至扁桃体切除术组。对照组中有 1 例患者出现严重咽炎(差异 3%,95%置信区间[CI] -2%至 7%),而扁桃体切除术组无患者出现严重咽炎。对照组中有 17 例患者(43%)和扁桃体切除术组中有 2 例患者(4%)因咽炎就诊(差异 38%,95%CI 22%至 55%)。总体而言,对照组中有 32 例患者(80%)和扁桃体切除术组中有 18 例患者(39%)在 5 个月随访期间出现咽炎发作(差异 41%,95%CI 22%至 60%)。扁桃体切除术组的咽炎发生率和症状持续天数明显低于对照组。
对照组和治疗组的严重咽炎发作次数无显著差异,且发作少见。然而,扁桃体切除术可减少咽炎症状,从而减少就诊次数和缺课/旷工天数。因此,手术可能对某些患者有益。
ClinicalTrials.gov,编号 NCT00547391。